Inogen Inc INGN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $9.12
- Day Range
- $8.97–9.38
- 52-Week Range
- $4.13–13.33
- Bid/Ask
- $9.14 / $9.16
- Market Cap
- $217.27 Mil
- Volume/Avg
- 267,124 / 203,913
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.65
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 834
- Website
- https://www.inogen.com
Comparables
Valuation
|
Metric
|
INGN
|
301033
|
688161
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 56.87 | 101.26 |
Price/Book Value | 1.15 | 4.95 | 2.91 |
Price/Sales | 0.65 | 11.79 | 9.32 |
Price/Cash Flow | — | 33.90 | 69.09 |
Price/Earnings
INGN
301033
688161
Financial Strength
|
Metric
|
INGN
|
301033
|
688161
|
|---|---|---|---|
Quick Ratio | 2.14 | 4.60 | 2.16 |
Current Ratio | 2.70 | 6.54 | 4.05 |
Interest Coverage | — | 40.89 | 91.82 |
Quick Ratio
INGN
301033
688161
Profitability
|
Metric
|
INGN
|
301033
|
688161
|
|---|---|---|---|
Return on Assets (Normalized) | −11.95% | 7.51% | 1.75% |
Return on Equity (Normalized) | −18.30% | 8.88% | 2.31% |
Return on Invested Capital (Normalized) | −19.17% | 8.37% | 1.76% |
Return on Assets
INGN
301033
688161
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Synddrl | Fhmcpj | $196.0 Bil | |||
| Stryker Corp
SYK
| Pqtrknwrhj | Czb | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Trzfzpyp | Zcnrwg | $124.5 Bil | |||
| Medtronic PLC
MDT
| Kymghjwtr | Khlmlzp | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Xddqrmxhl | Lsnyq | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Swp | Fxw | $30.2 Bil | |||
| DexCom Inc
DXCM
| Gqtxwjlq | Mbryn | $27.3 Bil | |||
| Steris PLC
STE
| Cyxydmh | Ckvwv | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Bvxwptgfps | Dpss | $21.3 Bil | |||
| Insulet Corp
PODD
| Mgrljtlvgx | Dvwqns | $16.1 Bil |
United States